Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia.
J Mov Disord
; 14(1): 75-77, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-961921
ABSTRACT
Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of the drug. We present a case of a 38-year-old male who was started on HCQ for COVID-19 pneumonia. He was referred for evaluation of myoclonus of all extremities, which resolved after discontinuation of HCQ. The involuntary movements were first reported after the initiation of HCQ, persisted despite improvement in inflammatory and radiologic parameters and eventually resolved after HCQ discontinuation. This supports a possible causality related to adverse drug reactions from HCQ that have not been commonly reported.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Experimental Studies
Language:
English
Journal:
J Mov Disord
Year:
2021
Document Type:
Article
Affiliation country:
Jmd.20091
Similar
MEDLINE
...
LILACS
LIS